Skip to main content
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: Cancer Res. 2010 Jan 12;70(2):471–480. doi: 10.1158/0008-5472.CAN-09-2863

Figure 4. Expression of CXCL12 or PGK1 alters the phenotype of NSFs.

Figure 4

Figure 4

(A) Immunofluorescence staining for α-SMA in NSFCXCL12, NSFPGK1, NSFControl, and CAFcontrol cells Expression of α-SMA (green) is higher in NSFPGK1 and CAFcontrol cells than in NSFControl cells. Original magnification 40×, where the bars represents 50 μM.

(B) Vimentin staining of NSFCXCL12, NSFPGK1, NSFControl, and CAFcontrol cells. Representative immunohistochemical staining for vimentin (brown, nuclear) is presented. Original magnification 40×, where the black bars represents 50 μM.